Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03509467 · ClinicalTrials.gov registry record · NA
Using MC1R Genotype to Impact Melanoma Risk Behavior
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 2,054
- Enrollment target
NCT03509467 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 2,054 participants.
The verdict
NCT03509467, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,054 participants
- Enrollment target
Study Summary
The purpose of this study is to examine how different messages about risk of melanoma can impact the way people protect themselves against developing these diseases.
Interventions
- BEHAVIORAL Personalized Information
- BEHAVIORAL Standard Information
- OTHER DNA Extraction Determination of MC1R Genotypes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,054 participants |
| Start Date | 2015-08-03 |
| Est. Completion | 2021-02-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03509467
The ClinicalTrials.gov registry entry for NCT03509467 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,054 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Personalized Information is the first listed.
NCT03509467 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03509467 about?
NCT03509467 is a clinical study titled "Using MC1R Genotype to Impact Melanoma Risk Behavior". The purpose of this study is to examine how different messages about risk of melanoma can impact the way people protect themselves against developing these diseases.
What is the current status of trial NCT03509467?
This trial is currently completed. It is a NA study. The enrollment target is 2,054 participants. The study started on 2015-08-03. Estimated completion is 2021-02-19.
What interventions are being tested in trial NCT03509467?
The interventions under investigation include: Personalized Information (BEHAVIORAL), Standard Information (BEHAVIORAL), DNA Extraction Determination of MC1R Genotypes (OTHER).
Who is sponsoring clinical trial NCT03509467?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.